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Although being a frequent condition in the oral cavity, still no adequate therapeutic possibilities for 
the treatment of hyposalivation exist. The aim of this review article was to summarize knowledge already 
published on the Pubmed evaluating the topical therapeutic possibilities with regard to the hyposalivation. The 
results of this review have shown that every topical treatment applied in patients with dry mouth alleviates 
symptoms of hyposalivation. However, it is still inconclusive which topical treatment is the best option for 
patients dry mouth symptoms. 
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INTRODUCTION 
 
Hyposalivation is the objective finding of decreased salivary flow rate unlike xerostomia which is 
subjective feeling of dry mouth. Hyposalivation can be caused by various conditions/diseases. Certain inherited 
diseases of the salivary glands such as triple A syndrome might result in dry mouth. Acquired diseases of the 
salivary glands such as obstructive ones (sialolithiasis, tumors) as well as microbial ones (actinomycosis, 
tuberculosis, cat-scratch disease, toxoplasmosis, HIV and hepatitis) might result in dry mouth. Systemic 
diseases of the salivary glands such as Sjogren's syndrome, sarcoidosis, depression and anxiety as well as 
kidney and heart failure might also lead to the dry mouth. Most frequently side effect of drug intake is the 
cause of dry mouth. More than 500 drugs are implicated in the hyposalivation. Unfortunately the drugs most 
frequently used are antihypertensives and psychotropic drugs and are the ones causing dry mouth. The 
diagnosis of hyposalivation can be obtained by relatively simple sialometry test which shows ammount of 
salivary secretion through the period of five minutes while the examinee sits in the chair. Stimulated salivary 
flow can be obtained by use of the sour beverages (citric acid) orparaffin gum in the same manner. 
Additionally, other diagnostic procedures are available and might be helpful when in doubt such as x-ray, 
ultrasound with fine needle aspiration, sialography, scintigraphy, magnetic resonance, computerized 
tomography and sometimes even biopsy of the minor salivary glands (lower lip) or major salivary glands [1]. 
Literature data offer a great deal of either local or systemic salivary stimulants/substitutes, however these are 
still in many sufferers inadequate. Current therapies rely on saliva substitutes and pharmacological stimulation 
of the parasympathetic system. These treatment modalities are somewhat limited by their short-term efficacy, 
high cost and drug interactions or other adverse effects [2]. Various substitutes with different ingredients are 
available for topical and symptomatic therapy, but there are no generally accepted treatment suggestions due 
to the lack of studies proving effective relief of symptoms. Levine et al [3]. concluded that an ideal artificial 
saliva should be "long-lasting", provide lubrication, inhibit colonization of microflora responsible for dental 
caries and gingivitis, and coat the oral soft tissues for protection against environmental insult and desiccation.  
 
MATERIALS AND METHODS 
 
We have performed Pubmed search from the year 1994 to 2014 in order to find out used topical 




Table 1: List of authors and used topical therapies for dry mouth. 
 
AUTHORS TOPICAL THERAPIES 
Alpoz et al. Mineral dental water spray. 
Alpoz et al. Xialine 
Sweeney et al. Mucin containing/mucin free spray 
Mouly et al. Oxygenated glycerol triester spray 
Shirodaria et al. OASIS Mouth Mositurizing Spray 
Hofauer et al. LipoSaliva 
Lopez Jornet et al. Toothpaste and mouthwash (triclosan, fluoride, gingival revitalizers, mineral salts). 
Femiano et al. Artifical saliva and citric acid 
Shahdad et al. Bioxtra/Biotène Oralbalance 
Johansson et al. Salinum (linseed mucilage) 
Andersson et al. Salinum (linseed mucilage) 
Khursudian Oral lozenge of interferon-alpha 
 




In the existing literature, there are studies regarding topical tretament of dry mouth based on the 
studies investigating either comparison between salivary substitutes and placebo or comparison between the 
two different salivary substitutes. 
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Alpöz et al. [4] concluded that the commercial mineral water dental spray was not more efficient than 
placebo in the management of dry mouth-related symptoms. On the contrary, the results of our study (still 
unpublished data) show that mineral spray was superior to the commercial artificial saliva and marshmallow 
root. Another study by Alpoz et al. [5] showed that Xialine was more preferred by patients suffering from 
Sjőgren's syndrome in comparison to the placebo. Sweeney et al. [6] concluded that there was no evidence for 
increased benefit of a mucin-containing spray over a mucin-free placebo among 35 xerostomic hospice 
patients. However, it was clear that both sprays provided worthwhile symptomatic relief of oral dryness for 
many of the participants. Mouly et al. [7] reported that new oxygenated glycerol triester oral spray taken five 
times daily was superior to Saliveze in improving xerostomia and oral tissue condition in 41 older 
institutionalised patients. Shirodaria et al. [8] documented that OASIS Mouth Moisturizing Spray helped 
provide dry mouth relief in 24 participants in comparison to the Saliveze. Hofauer et al. [9] concluded that 
liposomal local therapy (LipoSaliva®) caused a significant reduction of xerostomia in patients with primary sicca 
syndrome, however, there was no control group.  López-Jornet et al. [10] concluded that the use of a 
toothpaste and mouthwash based on triclosan, fluoride, gingival revitalizers and mineral salts, improves the 
quality of life of 30 patients suffering xerostomia in comparison to the placebo. Femiano et al. [11] reported 
that both artificial saliva and citric acid provided immediate relief from oral dryness in 54 patients with 
xerostomia. Citric acid also provided a longer-lasting feeling of oral moistness at 1 hour after use owing to its 
protracted activity on salivary gland function. Shahdad et al. [12] concluded that both treatments (Bioxtra and 
Biotène Oralbalance) were effective in alleviating the symptoms of 20 post-radiotherapy xerostomic patients, 
although Bioxtra achieved superiority in some of the outcomes assessed compared with Biotene. Johansson et 
al. [13] concluded that positive effects on symptoms in patients with Sjögren's syndrome were seen after use 
of Salinum without or with chlorhexidine. Andersson et al. [14] reported that the linseed mucilage significantly 
reduced the symptoms of dry mouth in 20 patients with xerostomia, who had been treated for cancer in the 
head and neck by radiation in comparison to the sodium carboxymethyl cellulose preparation . This effect 
increased with increasing time of saliva substitute use. The linseed mucilage Salinum appeared to be a suitable 
saliva replacement in mouth dry patients. Johansson et al. [15] reported that in the majority of the patients 
out of 37 tested, the use of Salinum (water soluble extract of linseed) reduced the symptoms of hyposalivation 
and generally the patients with the most severe symptoms experienced the greatest relief of the symptoms 
when they used Salinum. Furthermore, Furness et al. [16] reported that there is no strong evidence that any 
topical therapy is effective for relieving the symptom of dry mouth. Oxygenated glycerol triester spray is more 
effective than an aqueous electrolyte spray whereas there is no evidence that gum is better or worse than 
saliva substitutes. Khurshudian [17] reported that oral lozenges of 150 IU interferon-alpha 3 times a day for 
the 8 patients with primary Sjögren's syndrome improved saliva production, relieved symptoms of xerostomia 
and xerophthalmia, and was well tolerated by the patients in comparison to the four patients treated with 
placebo. 
 
It seems that in patients with dry mouth topical application of solutions/gels/sprays/toothpastes 
alleviates dry mouth symptoms no matter what their constituents are. However, we can not conclude which of 
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